Document is current

Any future updates will be listed below

Benefit of adjuvant chemotherapy with or without trastuzumab in pT1ab node-negative human epidermal growth factor receptor 2-positive breast carcinomas: results of a national multi-institutional study

Crossref DOI link: https://doi.org/10.1007/s10549-017-4136-5

Published Online: 2017-02-02

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark